Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOMP in relapsed B-cell chronic lymphocytic leukemia
NCT01612988Phase 2Terminated
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Jul 2012
- Primary completion
- Dec 2015
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ofatumumab in chronic lymphocytic leukemia (CLL), sponsored by French Innovative Leukemia Organisation. Started Jul 2012; status: terminated.
02
Drugs
ofatumumab
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT01612988.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01612988.